U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Substance Use Tools & Resources   

Read the Guide

This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 [PDF 0.69 MB] and Volume 2 [PDF 1.28 MB] of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.

Displaying 61 - 70 of 79

How to Track Treatment Progress and Adherence with the ASAM Criteria (Slides)

The slides from this informative webinar will aid drug court team members in tracking treatment progress and ensuring that participants adhere to medication in addiction treatment. jointly sponsored by the National Association of Drug Court Professionals and the American Society of Addiction Medicine, this webinar was designed especially for judges, coordinators, prosecutors, defense attorneys, supervision officers, case managers, and other team members who refer, monitor, or otherwise support behavioral health treatment in drug courts.

Format
Webinar/Video
Audience
Behavioral Health Providers
Other Team Members
Source
American Society of Addiction Medicine
Year
Resource Type
Video

Drug Safety Communications - FDA warns about dental problems with buprenorphine medicines dissolved in the mouth to treat opioid use disorder and pain

This is an FDA warning that dental problems have been reported with medicines containing buprenorphine that are dissolved in the mouth. Despite these risks, buprenorphine is an important treatment option for opioid use disorder (OUD) and pain, and the benefits of these medicines clearly outweigh the risks.
Format
Web Page
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Patients
Families
Communities
Source
U.S. Food & Drug Administration (FDA)
Year
Resource Type
Web Page

Matrix Intensive Outpatient Treatment for People With Stimulant Use Disorders: Client's Handbook

Contains handouts that clients will need for treatment. Includes handouts for three types of sessions: Individual/ Conjoint, Early Recovery Skills, and Relapse Prevention.
Format
Guide
Audience
Patients
Families
Source
Substance Abuse and Mental Health Services Administration (SAMHSA)
Year
Resource Type
PDF
File Size
1.15 MB

Pain Management and the Opioid Epidemic: Balancing Societal and Individual Benefits and Risks of Prescription Opioid Use

This guideline updates the state of the science on pain research, care, and education with a particular focus on informing the Food and Drug Administration's (FDA's) development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
Format
Guide
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Policymakers and Payers
Source
The National Academies of Sciences, Engineering, and Medicine
Year
Resource Type
PDF
File Size
11.2 MB